$CDT News

CDT Equity Receives Nasdaq Noncompliance Letter

CDT Equity Secures Canadian Patent Covering Use Of AZD5904 In Male Infertility

CDT Equity Unit Sarborg Files Parent Covering Two Established Compounds Within The Cystic Fibrosis Market

CDT Equity shares are trading lower after the company announced that it expects to report a year-over-year increase in FY25 net loss.

CDT Equity shares are trading lower after the company announced that it expects to report a year-over-year increase in FY25 net loss.

CDT Equity Files For Non-Timely 10-K With U.S. SEC;For Year Ended Dec 31, 2025, Anticipates Net Loss Will Increase By About $(21.3M)

Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

CDT Equity Submits Two New Patent Applications Over Combination Therapy Pairing Tapinarof With Drugs In Psoriasis, Atopic Dermatitis

CDT Equity shares are trading lower after the company announced a 1-for-25 reverse stock split.

CDT Equity Announces 1-For-25 Reverse Stock Split, Effective March 26

CDT Equity Completes Initial Signature Mapping Of Its Asset Portfolio Against Sarborg's Rare Disease Database

CDT Equity Announces Sarborg Expands Its AI Signature Agent Platform Through Curation Of Rare Disease Signature Database

CDT Equity Highlights Sarborg's Filing Of U.S. Provisional Patent For Proprietary AI Signature Agent

CDT Equity Notes Sarborg Expansion into Bacteria and Agrochemicals

12 Health Care Stocks Moving In Friday's After-Market Session

CDT Acquires Strategic Stake in Sarborg to Transform its AI-Driven Asset Strategy

CDT Equity shares are trading higher after the company announced it will acquire 20% equity in Sarborg.

CDT Equity Signs Transaction To Acquire 20% Equity In Sarborg For $115M

12 Health Care Stocks Moving In Friday's Pre-Market Session